Primary Driver in the Lupus Nephritis Market 2025: Rising Genetic Predisposition Driving The Growth Of The Market
Lupus Nephritis Global Market Report 2025
The Business Research Company's Lupus Nephritis Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, May 13, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts Through 2034
The lupus nephritis global market report reveals the steady ascent of the market from $1.94 billion in 2024 to an expected $2.09 billion in 2025, demonstrating a compound annual growth rate CAGR of 7.9%. This historical growth is credited to numerous factors including burgeoning research investments in lupus nephritis, the rising incidence of autoimmune diseases, increasing healthcare expenditure, growing adoption of biologics, and the rise of telemedicine.
Is the Lupus Nephritis Market Set to Witness Substantial Growth?
Stepping firmly into the future, the lupus nephritis market is estimated to witness a momentous escalation, reaching an estimate of $2.80 billion in 2029 with a CAGR of 7.6%. The forecasted growth can be ascribed to an array of factors including a heightened awareness among physicians, the rising adoption of biologic therapies, an increased number of specialty clinics, a burgeoning consideration towards renal transplantation, and enhanced accessibility to nephrology services. Emerging trends such as advancements in biologic therapies, personalized medicine approaches, novel diagnostic biomarkers, expansion of clinical trials, and advancements in stem cell therapy, are believed to significantly shape the market development.
Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22044&type=smp
What Drives The Lupus Nephritis Market Growth?
Moving forward, genetic predisposition is anticipated to fuel the growth of the lupus nephritis market. Genetic predisposition implies the inherited genetic traits of an individual that increases their likelihood of developing certain diseases or conditions. This increasing prevalence of genetic predisposition can be credited to a mix of inheritance, environmental influences, and mutations in specific genes. The influencing power of inherited genetic factors in autoimmune diseases, particularly those affecting kidney function, can be seen through the lens of lupus nephritis development. In a notable instance, in October 2024, the UK CF Registry recorded a 1.52% increase in individuals with cystic fibrosis CF compared to two years earlier, underlining the growing prevalence of genetic disorders.
Who Are The Key Players In The Lupus Nephritis Market?
The hallmark companies operating within the lupus nephritis market feature an impressive array of renowned corporations such as F. Hoffmann-La Roche Ltd., Bristol Myers Squibb, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Genentech, Astrazeneca PLC, Biocon Biologics, Hanmi Pharmaceutical Co. Ltd., Sana Biotechnology Inc., RemeGen Co. Ltd., Aurinia Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Equillium Inc., Anthera Pharmaceuticals Inc., Atara Biotherapeutics Inc., amongst others.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/lupus-nephritis-global-market-report
What Are The Emerging Trends In The Lupus Nephritis Market?
Capitalizing on advanced technologies and emerging trends, companies such as Aurinia Pharmaceuticals Inc. are focusing on streamlining second-generation calcineurin inhibitors to augment treatment efficacy and improve kidney outcomes for lupus nephritis patients. For instance, the Japanese Ministry of Health approved Aurinia's LUPKYNIS voclosporin for the treatment of lupus nephritis in September 2024.
How Is The Lupus Nephritis Market Segmented?
A comprehensive market segmentation of the lupus nephritis market includes a split by
1 Stage: Class 1, Class 2, Class 3, Other Stages
2 Drug Class: Immunosuppressive Drugs, Corticosteroids, Biological Agents, Antimalarial Drugs
3 Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4 Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5 End-User: Hospitals, Specialty Clinics, Other End-Users
This also extends to subsegments:
1 By Class 1: Asymptomatic Cases, Mild Proteinuria, Incidental Diagnosis
2 By Class 2: Mild Hematuria, Low-Grade Proteinuria, Minimal Immune Complex Deposition
3 By Class 3: Active Lesions, Chronic Sclerotic Lesions, Crescent Formation
4 By Other Stages: Class 4 Diffuse Lupus Nephritis, Class 5 Membranous Lupus Nephritis, Class 6 Advanced Sclerotic Lupus Nephritis
What Is The Regional Analysis Of Lupus Nephritis Market?
From a regional perspective, Asia-Pacific pioneered the frontier of the lupus nephritis market in 2024. Other regions covered in the report include Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Browse Through More Similar Reports By The Business Research Company:
Systemic Lupus Erythematosus Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/systemic-lupus-erythematosus-treatment-global-market-report
Diabetic Kidney Disease Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report
Artificial Kidney Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/artificial-kidney-global-market-report
Concluding on a high note, The Business Research Company boasts an impressive track record offering comprehensive, data-rich research, and insights with over 15000+ reports from 27 industries covering 60+ geographies. The company possesses 1,500,000 datasets along with a deep contribution of secondary research and unique industry leader insights allowing you to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us: info@tbrc.info
Stay connected:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Distribution channels: Business & Economy, Companies, Healthcare & Pharmaceuticals Industry, International Organizations, World & Regional
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release